Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-07-29 4:38 pm Sale | 13D | CORVUS PHARMACEUTICALS INC CRVS | Novo Holdings A/S | 2,927,560 9.98% | -1,492,956 (-33.77%) | View |
| 2019-07-23 4:46 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 10.62% | 2,445,147 (New Position) | View |
| 2019-07-01 4:52 pm Sale | 13G | NABRIVA THERAPEUTICS AG NBRV | Novo Holdings A/S | 3,446,564 4.74% | -1,257,156 (-26.73%) | View |
| 2019-07-01 4:48 pm Purchase | 13D | MORPHIC HLDG INC MORF | Novo Holdings A/S | 2,645,446 8.94% | 2,645,446 (New Position) | View |
| 2019-05-14 4:30 pm Purchase | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,674,470 11.31% | 2,674,470 (New Position) | View |